Syngene International share price
You have to be logged in to add this to Watchlist.- ₹754.00(2.52%)April 23, 2025 15:29:58 PM IST
- NSE
- BSE
- Vol : 658.86K (NSE + BSE)Last 20 day avg : 659.12 K
Syngene International is trading 2.52% upper at Rs 754.00 as compared to its last closing price. Syngene International has been trading in the price range of 754.00 & 734.00. Syngene International has given -15.59% in this year & 4.76% in the last 5 days. There are 10 analysts who have initiated coverage on Syngene International. There are 2 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 131.10 Crores in its last quarter.Listed peers of Syngene International include Suven Pharmaceuticals (-2.59%), Piramal Pharma (-0.40%), Syngene International (2.52%).The Mutual Fund holding in Syngene International was at 17.86% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 19.47% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 23, 2025, 11:43 AM UTC
- Dividend YieldLower than industry0.17Annual dividends as a percentage of the stock price.
- P/BIn line with historical values6.82The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values58.09Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation7.37The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- BetaMedium volatility0.90Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 10.57% from Rs 943.70 crore to Rs 853.50 crore, year-on-year
- The company has grown its December quarter profit by 17.58% from Rs 111.50 crore to Rs 131.10 crore, year-on-year
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 773.83
- R2
- 821.57
- R3
- 882.18
- S1
- 665.48
- S2
- 604.87
- S3
- 557.13
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Suven Pharmaceuticals | Bullish | 1,201.15 | -2.59 | 30,731.01 | 101.08 | 14.92 | - | 1.04 |
| Piramal Pharma | Bullish | 223.65 | -0.40 | 29,650.36 | 479.90 | 3.69 | 0.05 | 32.89 |
| Syngene International | Neutral | 754.00 | 2.52 | 30,342.94 | 55.89 | 6.82 | 0.17 | 10.92 |
| J B Chemicals And Pharmaceutical | Bearish | 1,588.20 | -4.06 | 24,749.47 | 47.59 | 8.81 | 0.74 | 1.14 |
| Gland Pharma | Moderately Bearish | 1,477.00 | 1.85 | 24,389.26 | 31.24 | 2.76 | 1.37 | 1.62 |
- Promoter(s) holds a high stake in the company at 52.74%
Promoter(s) have decreased the stake in the company in last 12 months- FIIs are invested in this company
- FIIs holding has decreased by 1.18 percentage points from previous quarter
- Mutual Funds holding has increased by 2.46 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-07-24 | Quarterly Results |
| 2024-04-24 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE398R01022
- BSE Code539268
- NSE CodeSYNGENE
Syngene International is trading at 754.00 as on Wed Apr 23 2025 09:59:58. This is 2.52% upper as compared to its previous closing price of 735.45.
The market capitalization of Syngene International is 30342.94 Cr as on Wed Apr 23 2025 09:59:58.
The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 1 analysts have given a hold rating
- 3 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Syngene International is 960.00 whereas the 52 wk low is 608.00
Syngene International can be analyzed on the following key metrics -
- TTM P/E: 68.71
- Sector P/E: -
- Dividend Yield: 0.17%
- D/E ratio: -
Syngene International reported a net profit of 510.00 Cr in 2024.
The Mutual Fund Shareholding was 17.86% at the end of 31 Mar 2025.